Terumo Corporation Stock (4543) - Quote Japan Exchange- MarketScreener (2024)

Market Closed - Japan Exchange Other stock markets 02:00:00 2024-06-18 am EDT			5-day change	1st Jan Change
2,590 ^JPY	+0.58%		-4.80%	+12.05%

Jun. 11	Japan's Nikkei rises on US stocks, heavyweight chip shares	RE
May. 28	Terumo Cardiovascular Announces 510(K) Clearance for the CDI Oneview?? Monitoring System	CI

Financials

Sales 2024	922B 5.84B	Sales 2025 *	991B 6.28B	Capitalization	3,823B 24.21B
Net income 2024	106B 674M	Net income 2025 *	127B 803M	EV / Sales 2024	4.42x
Net Debt 2024	26.96B 171M	Net cash position 2025 *	52.98B 336M	EV / Sales 2025 *	3.8x
P/E ratio 2024	38.2x	P/E ratio 2025 *	30.2x	Employees	30,207
Yield 2024	0.81%	Yield 2025 *	1%	Free-Float	95.63%

More Fundamentals * Assessed data

Chart Terumo Corporation

Duration

Period

Style

Dynamic Chart

Latest news about Terumo Corporation

Japan's Nikkei rises on US stocks, heavyweight chip shares	Jun. 10	RE
Terumo Cardiovascular Announces 510(K) Clearance for the CDI Oneview?? Monitoring System	May. 28	CI
Correction: Terumo’s Profit Up 47% in Fiscal 2024	May. 15	MT
Terumo’s Profit Up 47% in Fiscal 2023	May. 15	MT
Transcript : Terumo Corporation, 2024 Earnings Call, May 14, 2024	May. 14
Terumo Corporation Announces Fiscal Year-End Dividend for the Fiscal Year Ended March 31, 2024, Payable on June 27, 2024; Provides Second Quarter-End and Year-End Dividend Guidance for the Fiscal Year Ending March 31, 2025	May. 14	CI
Terumo Corporation Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2025	May. 14	CI
Penumbra, Inc. : The underdog in healthcare	Apr. 11
Frontier Field Co., Ltd. announced that it has received funding from Terumo Corporation	Mar. 17	CI
Jefferies Adjusts Terumo’s Price Target to 6,700 Yen From 5,300 Yen, Keeps at Buy	Mar. 13	MT
Tranche Update on Terumo Corporation's Equity Buyback Plan announced on August 9, 2023.	Mar. 11	CI
Terumo Corporation's Equity Buyback announced on August 9, 2023, has closed with 3,380,000 shares, representing 0.45% for ¥11,097.09 million.	Mar. 07	CI
Terumo Repurchases 521 Million Yen Shares in February	Mar. 04	MT
Terumo Corp to Undertake One-to-Two Share Split	Feb. 08	MT
Terumo's Attributable Profit Climbs 13.8% in Fiscal Nine Months	Feb. 07	MT

More news

Latest transcript on Terumo Corporation

Terumo Corporation, 2024 Earnings Call, May 14, 2024

May. 14

Analyst Recommendations on Terumo Corporation

Jefferies Adjusts Terumo’s Price Target to 6,700 Yen From 5,300 Yen, Keeps at Buy	Mar. 13	MT
Jefferies Adjusts Terumo's Price Target to 5,300 Yen From 4,500 Yen, Keeps at Buy	Jan. 04	MT
Japan's Nikkei falls on Fed rate hike prospects, China recovery concerns	23-08-17	RE
Japan's Nikkei hits 2-1/2-month low on concerns over Fed rate hike, China economy	23-08-16	RE
Jefferies Downgrades Terumo to Hold From Buy, Adjusts Price Target to 4,500 Yen From 4,900 Yen	23-08-14	MT

More recommendations

Press releases Terumo Corporation

Terumo Cardiovascular Announces 510(K) Clearance for the CDI OneView Monitoring System	May. 29	AQ
Terumo : NICE PUBLISHES A GUIDANCE SUPPORTING THE USE OF SELECTIVE INTERNAL RADIATION THERAPY FOR NEUROENDOCRINE TUMORS WITH LIVER METASTATIS	May. 16	PU
	May. 16	PU
Terumo : Financial Results for the Fiscal Year Ended March 31, 2024 (FY2023)(with note)	May. 15	PU
Terumo : The Future of Terumo "Our vision and the path to it"	May. 14	PU

More press releases

News in other languages on Terumo Corporation

Les actions mèmes rugissent à nouveau	May. 14
En Direct des Marchés : Veolia, Stellantis, BNP Paribas, Bayer, Anglo American, Rheinmetall, Uber...	May. 14
Penumbra, Inc. : El desvalido de la atención sanitaria	Apr. 15
MÄRKTE ASIEN/Tokio sehr fest auf 34-Jahreshoch - Softbank mit Kurssprung	Feb. 08
MÄRKTE ASIEN/Alibaba belasten HSI - Softbank treiben Nikkei	Feb. 08

More news

Quotes and Performance

1 day	+0.58%
1 week	-6.38%
Current month	-3.01%
1 month	-6.65%
3 months	-10.83%
6 months	+10.85%
Current year	+12.05%

More quotes

Highs and lows

1 week

2 540.00

2 735.00

1 month

2 540.00

2 815.00

Current year

2 267.00

3 014.50

1 year

1 856.00

3 014.50

3 years

1 708.00

3 014.50

5 years

1 440.00

3 014.50

10 years

552.75

3 014.50

More quotes

Managers and Directors - Terumo Corporation

Managers	Title	Age	Since
Toshiaki Takagi CHM	Chairman	66	81-03-31
Naoki Muto DFI	Director of Finance/CFO	-	-
Kazuhisa Senshu CTO	Chief Tech/Sci/R&D Officer	-	-

Members of the board	Title	Age	Since
Shouji Hatano CMP	Compliance Officer	64	83-03-31
Hidenori Nishi BRD	Director/Board Member	73	20-06-24
Shinjiro Sato BRD	Director/Board Member	63	04-05-31

More insiders

ETFs positioned on Terumo Corporation

Name	Weight	AuM	1st Jan change	Investor Rating
	2.24%	29 M€	+15.90%
DAIWA ETF-NIKKEI 225 ETF - JPY	1.94%	28,050 M€	+15.82%	-
MAXIS NIKKEI 225 ETF - JPY	1.90%	14,619 M€	+14.90%	-
NOMURA NIKKEI 225 EXCHANGE TRADED FUND ETF - JPY	1.82%	62,153 M€	+15.78%

More ETFs positioned on Terumo Corporation

Quotes

Date	Price	Change	Volume
24-06-18	2,590	+0.58%	2 931 400
24-06-17	2,574	-1.94%	3,362,900
24-06-14	2,626	+0.31%	6,942,400
24-06-13	2,618	-2.80%	4,052,700
24-06-12	2,693	-2.64%	3,012,500

Delayed Quote Japan Exchange, June 18, 2024 at 02:00 am EDT

More quotes

Company Profile

Terumo Corporation specializes in the design, manufacturing and marketing of medical products and equipments. Net sales break down by family of products as follows:- cardiac surgery devices (53.5%);- medical products for hospitals (28.6%): medical devices, nutritional additives, oxygen, medical measuring devices (thermometers, tensiometers, glucometers, etc.), etc.;- sanguine transfusion equipments (17.9%).Net sales break down geographically as follows: Japan (32.9%), America (29.5%), Europe (19.6%), China (7.4%) and other (10.6%).

Sector

Calendar

2024-06-25 - Annual General Meeting

Related indices

Nikkei 225

More about the company

Income Statement Evolution

More financial data

Ratings for Terumo Corporation

Trading Rating

Investor Rating

ESG Refinitiv

A-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

2,574JPY

Average target price

3,082JPY

Spread / Average Target

+19.69%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

	1st Jan change	Capi.
TERUMO CORPORATION	+12.05%	24.22B
ABBOTT LABORATORIES	-6.01%	180B
MEDTRONIC PLC	-2.95%	105B
BECTON, DICKINSON AND COMPANY	-4.54%	67.27B
DEXCOM, INC.	-6.09%	46.34B
CENCORA, INC.	+14.28%	46.22B
HOYA CORPORATION	+4.14%	40.1B
METTLER-TOLEDO INTERNATIONAL, INC.	+19.36%	30.92B
WEST PHARMACEUTICAL SERVICES, INC.	-4.56%	24.48B
ZIMMER BIOMET HOLDINGS, INC.	-12.05%	22.02B

Stock Market
Equities
4543 Stock

Secure and Increase the Performance of your Investments with our Team of Experts at your Side Securing my Investments

"); InvestingChannelQueue.push(function() { aICTags["oop"] = ic_page.defineOutOfPageTag("4Traders/quotepages","zppOOP"); aICTags["oop"].setKval({"adslot":"d_OOP_1"}); aICTags["oop"].render(); }); while (aAdsQueue.length) { (aAdsQueue.shift())(); } InvestingChannelQueue.push(function() { displayViewableAds('InvestingChannel'); $( window ).scroll(function() { displayViewableAds('InvestingChannel'); }); }); }gaEvent('adspv', 'InvestingChannel', 'US');googletag.cmd.push(function() { googletag.pubads().setTargeting('Edition', 'en_US');googletag.pubads().setTargeting('UserType', 'free');googletag.pubads().setTargeting('Content', 'equities');googletag.pubads().setTargeting('codezb', '6491240');googletag.enableServices();googletag.pubads().collapseEmptyDivs();try{googletag.pubads().getSlots().forEach(function(slot){if(slot.getSlotElementId().startsWith('zpp')){;}else{googletag.pubads().refresh([slot],{changeCorrelator: false});}})}catch(error){console.error(error)}});$(document).ready(function() { $( document).on('zbv_visible',function () {startAdsService();}); if (document[zbv_hidden]===false) { startAdsService(); } });